MARKER THERAPEUTICS, INC. Management Fees Revenue (Deprecated 2018-01-31)
MARKER THERAPEUTICS, INC. (MRKR) reported Management Fees Revenue (Deprecated 2018-01-31) of -$58.50 thousand for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-18.
Discontinued › Income Statement › Other Income
us-gaap:ManagementFeesRevenue · last filed 2014-08-18
- MARKER THERAPEUTICS, INC. management fees revenue (deprecated 2018-01-31) for the quarter ending 2014-06-30 was -$58.50K.
- MARKER THERAPEUTICS, INC. management fees revenue (deprecated 2018-01-31) for the quarter ending 2013-06-30 was -$58.50K.
| Period end | Management Fees Revenue (Deprecated 2018-01-31) 3 month | Management Fees Revenue (Deprecated 2018-01-31) 6 month | Management Fees Revenue (Deprecated 2018-01-31) 179 month |
|---|---|---|---|
| 2014-06-30 | -$58.50K 10-Q · filed 2014-08-18 | -$117.00K 10-Q · filed 2014-08-18 | -$3.46M 10-Q · filed 2014-08-18 |
| 2013-06-30 | -$58.50K 10-Q · filed 2014-08-18 | -$117.00K 10-Q · filed 2014-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |